Afif, W
Palanca A et al, Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes
People undergoing chemotherapy, taking immunosuppressive medications, living with HIV/AIDS, or dealing with other conditions that compromise immune function should consult their physician before starting any probiotic, including Pendulum
Early Discoveries, With More to Come So far, GLP-1s, first approved 20 years ago for type 2 diabetes and later obesity, have shown potential in treating a surprisingly wide range of conditions, such as heart disease, Parkinsons, Alzheimers, sleep apnea, and liver disease
It can cause severe stomach pain and may lead to serious complications
GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think about obesity, diabetes and weight loss